logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 3
  • 1
    Mrs Amanda Julie Naderali
    Born in March 1964
    Individual (3 offsprings)
    Person with significant control
    2016-11-25 ~ 2025-08-18
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Naderali, Mohammad Mahdi
    Company Director born in October 1995
    Individual (3 offsprings)
    Officer
    2017-08-17 ~ 2024-02-08
    OF - Director → CIF 0
  • 3
    Naderali, Ebrahim Khalil
    Born in May 1964
    Individual (6 offsprings)
    Officer
    2024-02-08 ~ now
    OF - Director → CIF 0
    Naderali, Ebrahim Khalil, Professor
    Pharmaceutical Consultancy born in May 1964
    Individual (6 offsprings)
    Officer
    2015-11-10 ~ 2017-08-17
    OF - Director → CIF 0
    Professor Ebrahim Khalil Naderali
    Born in May 1964
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

AVRIN PHARMA LTD

Period: 2017-11-21 ~ now
Company number: 09866322
Registered names
AVRIN PHARMA LTD - now
Standard Industrial Classification
86900 - Other Human Health Activities
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Turnover/Revenue
25,714 GBP2023-12-01 ~ 2024-11-30
7,973 GBP2022-12-01 ~ 2023-11-30
Profit/Loss
10,252 GBP2023-12-01 ~ 2024-11-30
1,583 GBP2022-12-01 ~ 2023-11-30
Fixed Assets
16,046 GBP2024-11-30
16,237 GBP2023-11-30
Current Assets
9,264 GBP2024-11-30
6,211 GBP2023-11-30
Creditors
Current, Amounts falling due within one year
-1,887 GBP2024-11-30
-1,379 GBP2023-11-30
Net Current Assets/Liabilities
7,377 GBP2024-11-30
4,832 GBP2023-11-30
Total Assets Less Current Liabilities
23,423 GBP2024-11-30
21,069 GBP2023-11-30
Creditors
Non-current, Amounts falling due after one year
-16,835 GBP2023-11-30
Net Assets/Liabilities
13,477 GBP2024-11-30
3,225 GBP2023-11-30
Equity
13,477 GBP2024-11-30
3,225 GBP2023-11-30
Average Number of Employees
12023-12-01 ~ 2024-11-30
12022-12-01 ~ 2023-11-30

  • AVRIN PHARMA LTD
    Info
    AVRIN CONSULTANCY LTD - 2017-11-21
    Registered number 09866322
    13 Walton Vale, Liverpool L9 4RE
    PRIVATE LIMITED COMPANY incorporated on 2015-11-10 (10 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2026-01-13
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.